SecBot SecBot

IVF

INVO Fertility, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. NV· CIK 0001417926 Healthcare & Medical Devices
$0.5700 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.5700
Market cap
$2.5M
Nano cap
Median target
$20.00
+3409% · range $20.00–20.00
1 year
−97.3%
from $21.40 · Oct 27
30 days
−39.0%
from $0.9340
52-week range
$0.5330–22.76
−97% from high · low Oct 22
Avg volume 20D
110.0K
shares / day
Short interest
🔒 Subscribers only
Filing reports
12
analyzed by SecBot
SecBot read BEARISH 5 reports · 90 days
Balance 4 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/5
Strongest BEARISH Glenbrook Capital Management filed an amended Schedule 13G reporting a reduction in its stake in INVO…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendDOWNTREND

    36% below its 50-day average. New closing low $0.5330 on Oct 22.

Who's buying

13F
Top holderSharesValue
SUSQUEHANNA INTERNATIONAL GROUP, LLP11,463$21.8K
DANSKE BANK A/S1$2.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12-month targets · 1 analysts

Price is below the lowest target. Median implies +3409%.Targets as of Oct 27, 2026.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 23, 2026
Earnings date
🔒 Fresh data, subscribers only
Recent
Sep 25, 2026
Company news
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility…
Sep 1, 2026
Reg SHO list
Reg SHO Threshold: IVF exited the threshold list
INVO FERTILITY INC COM PAR $0. | On list since 2026-07-24
Aug 17, 2026
Earnings
INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
Q2 2026 revenue increased 17% as INVO advances organic growth and a disciplined acquisition strategy focused on established, profitable fertility…
Aug 13, 2026
Earnings date
IVF Q2 2026 Earnings Scheduled — 2026-08-13
Aug 12, 2026
Earnings date
IVF Q2 2026 Earnings Scheduled — 2026-08-12

Earnings setup

Estimates
−$5.20
EPS estimate, this quarter
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$5.20-$5.20–-$5.20—$2.7M
Next Q-$4.40-$4.40–-$4.40—$3.3M
Current FY-$23.20-$23.20–-$23.20+80.3%$10.4M
Next FY-$8.00-$8.00–-$8.00+96.4%$16.5M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 9, 2026 SEC
Glenbrook Capital Management filed an amended Schedule 13G reporting a reduction in its stake in INVO Fertility, Inc…
SC 13G/A — Impact 4/10
Sep 25, 2026 Routine
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertili
Aug 28, 2026 SEC
INVO Fertility filed an 8-K disclosing an investor presentation for the H.C. Wainwright conference and providing an…
8-K — Impact 6/10
Aug 17, 2026 SEC
INVO Fertility reported Q2 2026 revenue of $2.18M (+17% YoY) and net income of $0.9M, swinging from a $(3.6)M loss in…
8-K — Impact 4/10
Jun 2, 2026 Press
INVO Fertility disclosed a Nasdaq delinquency notice for late filing of its 10-K (FY2025) and 10-Q (Q1 2026). The 10-K…
Impact 6/10
Mar 3, 2026 Press
INVO Fertility (IVF) announced that its Wisconsin Fertility Institute (WFI) clinic has joined the Progyny network, a…
Impact 4/10

SecBot reports

12 filings · 2 press releases · 1 bullish · 6 bearish · 2 mixed · 3 neutral
All IVF filing & press-release reports (14)